EYPT vs. SPY
Compare and contrast key facts about Eyepoint Pharmaceuticals Inc (EYPT) and State Street SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Performance
EYPT vs. SPY - Performance Comparison
Loading graphics...
EYPT vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EYPT Eyepoint Pharmaceuticals Inc | -28.74% | 145.23% | -67.76% | 560.29% | -71.41% | 86.02% | -57.55% | -17.99% | 75.00% | -36.84% |
SPY State Street SPDR S&P 500 ETF | -3.65% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Returns By Period
In the year-to-date period, EYPT achieves a -28.74% return, which is significantly lower than SPY's -3.65% return. Over the past 10 years, EYPT has underperformed SPY with an annualized return of -7.34%, while SPY has yielded a comparatively higher 14.06% annualized return.
EYPT
- 1D
- 1.01%
- 1M
- -29.01%
- YTD
- -28.74%
- 6M
- 0.81%
- 1Y
- 157.82%
- 3Y*
- 64.22%
- 5Y*
- 3.79%
- 10Y*
- -7.34%
SPY
- 1D
- 0.75%
- 1M
- -4.28%
- YTD
- -3.65%
- 6M
- -1.42%
- 1Y
- 18.14%
- 3Y*
- 18.48%
- 5Y*
- 11.86%
- 10Y*
- 14.06%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EYPT vs. SPY — Risk / Return Rank
EYPT
SPY
EYPT vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eyepoint Pharmaceuticals Inc (EYPT) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EYPT | SPY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.11 | 0.96 | +1.15 |
Sortino ratioReturn per unit of downside risk | 2.75 | 1.49 | +1.26 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.23 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 3.78 | 1.53 | +2.24 |
Martin ratioReturn relative to average drawdown | 9.96 | 7.27 | +2.69 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EYPT | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.11 | 0.96 | +1.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.70 | -0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.07 | 0.79 | -0.86 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | 0.56 | -0.65 |
Correlation
The correlation between EYPT and SPY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
EYPT vs. SPY - Dividend Comparison
EYPT has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.13%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EYPT Eyepoint Pharmaceuticals Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 1.13% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Drawdowns
EYPT vs. SPY - Drawdown Comparison
The maximum EYPT drawdown since its inception was -97.73%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for EYPT and SPY.
Loading graphics...
Drawdown Indicators
| EYPT | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.73% | -55.19% | -42.54% |
Max Drawdown (1Y)Largest decline over 1 year | -37.14% | -12.05% | -25.09% |
Max Drawdown (5Y)Largest decline over 5 years | -87.61% | -24.50% | -63.11% |
Max Drawdown (10Y)Largest decline over 10 years | -94.45% | -33.72% | -60.73% |
Current DrawdownCurrent decline from peak | -87.03% | -5.53% | -81.50% |
Average DrawdownAverage peak-to-trough decline | -76.33% | -9.09% | -67.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.08% | 2.54% | +11.54% |
Volatility
EYPT vs. SPY - Volatility Comparison
Eyepoint Pharmaceuticals Inc (EYPT) has a higher volatility of 20.37% compared to State Street SPDR S&P 500 ETF (SPY) at 5.35%. This indicates that EYPT's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EYPT | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.37% | 5.35% | +15.02% |
Volatility (6M)Calculated over the trailing 6-month period | 51.23% | 9.50% | +41.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.69% | 19.06% | +56.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 118.59% | 17.06% | +101.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 100.71% | 17.92% | +82.79% |